Authors
Latest:
When to Call, When to Counsel: Acetazolamide for Idiopathic Intracranial HypertensionIdiopathic intracranial hypertension was previously considered a rare condition, however, its prevalence is increasing in parallel with obesity in patient populations.
Latest:
The UK Became a Leader in the Cell Therapy Revolution, but a Lack of Ongoing Investment Could Change ThatAdvanced cell therapies are now saving the lives of people whose blood cancer would previously have been incurable. While the UK was quick to recognize the potential of these innovative therapies, patient access to these therapies may change without continued investment in the UK's cell therapy infrastructure.
Latest:
Comparative Oncology: Advances in Cancer Care from Pets to HumansDogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.
Latest:
Exploring the Vascular Benefits of Semaglutide in Peripheral Artery DiseaseMarc Bonaca, MD, PHH, FACC discussed semaglutide’s potential benefits for non-diabetic patients with peripheral artery disease.
Latest:
Fourth-Year Pharmacy Students Help Patients and Practitioners in Transitional CareStudents are being exposed to new patient experiences through collaboration with practitioners.
Latest:
Pharmacy-Led Medication Reconciliation Is Best PracticeThe TJC and IHI advocate for medication reconciliation at all transitions of care.
Latest:
Three Trends Shaping HIV Pharmacy CareAlthough quality of life has significantly improved for patients with HIV, there are several factors influencing how we provide care and treat patients now and in the future.
Latest:
AAN 2025: Tolebrutinib Shows Promise in Slowing Disability Progression for Secondary Progressive Multiple SclerosisThe HERCULES trial demonstrates tolebrutinib's potential to slow disability progression in non-relapsing secondary progressive multiple sclerosis, offering a new treatment option for patients with limited therapeutic choices.
Latest:
Metronidazole Twice Daily: A Pharmacokinetic and Clinical JustificationThis medication is associated with a number of adverse effects, such as gastrointestinal upset and peripheral neuropathies, that may be mitigated by less frequent dosing.
Latest:
To Deliver Cell and Gene Therapies to More Patients, Innovation in Diagnostic Testing is EssentialIndividualized treatments like cell and gene therapies are poised to scale rapidly over the next decade.
Latest:
Finerenone Shows Promise in Heart Failure and Kidney Disease ManagementJohn Ostrominski, MD shares insights into the safety and efficacy of finerenone, based on data from the FINEARTS-HF trial.
Latest:
Treating Acid Reflux With Over-the-Counter MedicationsAn overview of acid reflux and gastroesophageal reflux disease, over-the-counter options, long-term effects of proton pump inhibitors, lifestyle recommendations, and when to refer patients.
Latest:
Integrated Care Pathways and Future Directions in COPD Management at UPMCUPMC Health Plan enhances COPD care through personalized treatment, telemedicine, and comprehensive support, ensuring optimal patient outcomes and adherence.
Latest:
Marcella Kinaya, PharmD, on Flu Season: ‘We’re Here to Protect People and Make Sure They’re Healthy’A district leader at CVS Health emphasizes that patients should get tested, be up to date with immunizations, and staying home and reach out to health care professionals when experiencing symptoms.
Latest:
Improving Medication Guidance Needs to be a Top Priority for Hospitals, Health SystemsMore drugs plus a growing population of older and sicker patients is creating medication-alert overload for already stressed clinicians.
Latest:
Integrating Emotional Healing Through Psychedelics Into Everyday Oncology PracticeManish Agrawal, MD, discusses the implementation of psilocybin-assisted therapy in a community cancer setting, highlighting its potential to provide sustained relief from depression and anxiety and its significant efficacy advantage over selective serotonin reuptake inhibitors for patients with cancer.
Latest:
Innovative Strategies in Residency Training: Approaching Competencies, Quality Improvement, and AI IntegrationIncorporating AI into pharmacy education is crucial to training on its appropriate use.
Latest:
Case Study: Pharmacist Management of Inappropriate Prednisone Dosing Triggered By AsthmaHolistic and compassionate counseling by a pharmacist and pharmacy-interns on-duty over weekends could positively impact patient lives, especially for older adults and economically disadvantaged patients.
Latest:
Op-Ed: States Are Leading the Way on PBM Reform. Here’s How.Lawmakers across the country can learn from examples in states like Arkansas and Texas.
Latest:
Ambulatory Care Pharmacist-Administered Depression Screenings Can Close Gaps in CareThe study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.
Latest:
Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLCKevin Chen, PharmD, MS, BCOP, CPP; and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the newly approved drug taletrectinib.
Latest:
USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ DiseaseAchieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.
Latest:
A Pharmacist’s Guide to Lung Cancer and Its Key TreatmentsThough new treatments offer hope, careful monitoring and understanding of risks remain essential for their success.
Latest:
The Tao of Tau: Developing the “My Vancomycin Calculator” AppCreating a free app to assist in vancomycin dosing proved to be an entertaining and enlightening journey.
Latest:
Consider the Commissioned Corps of the United States Public Health Service for a Rewarding Pharmacy CareerWorking for the USPHS offers unique compensation and quality-of-life benefits.
Latest:
Driving Clinical Pharmacy Development With Data-Driven Metrics and InsightsThere are no clearly defined, widely accepted clinical pharmacist metrics.
Latest:
Looking Ahead: Research Priorities and Final InsightsPanelists discuss how advancing chronic graft-vs-host disease (cGVHD) management involves improving steroid response rates, exploring combination therapies, utilizing biomarkers for personalized treatment, and striving for steroid-free first-line options to enhance patient outcomes and reduce long-term adverse effects.
Latest:
Artificial Intelligence Applications in Education and Pharmacy PracticeBy interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
Latest:
An Overview of Vitamins and Supplements in Multiple SclerosisBy examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
